Zhang Shetuan, Lin Jijin, Hirano Yuji, Hiraoka Masayasu
Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre and Department of Physiology, Faculty of Medicine, University of Manitoba, Winnipeg, MB, Canada.
Can J Physiol Pharmacol. 2005 Nov;83(11):1015-24. doi: 10.1139/y05-058.
We found when L-type calcium current (ICa-L) was recorded with the perforated patch-clamp method in rat ventricular myocytes that bath application of phenylephrine (with propranolol) evoked a biphasic response characterized by an initial transient suppression followed by a sustained potentiation. The transient suppression occurred 30-60 s after phenylephrine perfusion and reached peak inhibition at approximately 2 min. The biphasic modulation of ICa-L was also elicited by methoxamine, and the effects of phenylephrine were blocked by prazosin, indicating that the responses were mediated through alpha1-adrenoceptors. Pretreatment of cells with H7 (100 micromol/L), a broad-spectrum protein kinase inhibitor that inhibits both protein kinase C and A, eliminated potentiation but did not affect transient suppression. The transient suppression occurred concurrently with the acceleration of the fast component of ICa-L inactivation. Depletion of intracellular Ca2+ stores by ryanodine plus caffeine or thapsigargin eliminated the transient suppression. When ICa-L was recorded with whole-cell patch-clamp and with 0.05 mmol/L EGTA in the pipette solution to allow intracellular Ca2+ to fluctuate, phenylephrine evoked a transient suppression as in the perforated patch recordings. Heparin, a specific blocker of IP3 (inositol 1,4,5-trisphosphate) receptors, eliminated the phenylephrine-induced transient suppression of ICa-L when added to the pipette solution. Intensive chelation of intracellular Ca2+ by 5 mmol/L BAPTA (1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid) in the pipette solution also eliminated the phenylephrine-induced transient suppression of ICa-L. We conclude that transient increase in the concentration of intracellular calcium ([Ca2+]i) caused by Ca2+ release from intracellular stores underlies the transient suppression of ICa-L, whereas the potentiation of ICa-L is a result of activation of protein kinases.
我们发现在大鼠心室肌细胞中用穿孔膜片钳法记录L型钙电流(ICa-L)时,浴槽中加入去氧肾上腺素(加普萘洛尔)会引起双相反应,其特征是最初的短暂抑制,随后是持续增强。短暂抑制在去氧肾上腺素灌注后30 - 60秒出现,约2分钟时达到最大抑制。甲氧明也能引起ICa-L的双相调节,且去氧肾上腺素的作用被哌唑嗪阻断,表明这些反应是通过α1 - 肾上腺素能受体介导的。用H7(100 μmol/L)预处理细胞,H7是一种抑制蛋白激酶C和A的广谱蛋白激酶抑制剂,可消除增强作用,但不影响短暂抑制。短暂抑制与ICa-L失活快速成分的加速同时发生。用ryanodine加咖啡因或毒胡萝卜素耗尽细胞内Ca2+储存可消除短暂抑制。当用全细胞膜片钳记录ICa-L且在电极液中加入0.05 mmol/L EGTA以使细胞内Ca2+波动时,去氧肾上腺素引起的短暂抑制与穿孔膜片记录中的情况相同。肝素是肌醇1,4,5 - 三磷酸(IP3)受体的特异性阻断剂,当加入电极液中时可消除去氧肾上腺素诱导的ICa-L短暂抑制。电极液中5 mmol/L 1,2 - 双(2 - 氨基苯氧基)乙烷 - N,N,N',N' - 四乙酸(BAPTA)对细胞内Ca2+的强烈螯合也可消除去氧肾上腺素诱导的ICa-L短暂抑制。我们得出结论,细胞内储存释放Ca2+导致细胞内钙浓度([Ca2+]i)短暂升高是ICa-L短暂抑制的基础,而ICa-L的增强是蛋白激酶激活的结果。